bivalent human IL-2 fused truncated diphtheria toxin (Celdara Medical)

N/A

Report date: 2025/03/14 16:39:50

Base Information

Drug Namebivalent human IL-2 fused truncated diphtheria toxin (Celdara Medical)
Drug Alias NameBILT (Celdara Medical)BILT
ClassificationBiologics > Protein drugs > Toxin
Mechanisms of ActionInterleukin-2 receptor alpha chain inhibitors
TargetsInterleukin-2 receptor alpha chain
Therapy Area/IndicationsLymphoma, T-Cell, Cutaneous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCeldara Medical Llc
China Registration ClassN/A

Develop Information

Active CompaniesCeldara Medical Llc
Inactive CompaniesN/A
Active IndicationsLymphoma, T-Cell, Cutaneous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A